Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy in Early Stage NSCLC
NCT00863512Phase 3Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 2009
- Primary completion
- Nov 2011
- Modality
- Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), vinorelbine, docetaxel, gemcitabine, pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Cancer and Leukemia Group B. Started Mar 2009; status: terminated.
02
Drugs
Cisplatin micelle injection (HA132)vinorelbinedocetaxelgemcitabinepemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00863512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863512.